Federal law allows insurers to pass along disidentified health information to employer plan sponsors, however, a law that went into effect in Texas in January now forces insurers to pass the information along.
Federal law allows insurers to pass along disidentified health information to employer plan sponsors, however, a law that went into effect in Texas in January now forces insurers to pass the information along.
Information will include beneficiaries with health bills exceeding $15,000, diagnoses, dates of service, cost of service, prognoses, treatment and future costs. Employers hope the data will help them better plan for healthcare expenses, but opponents of the law say it’s a clear violation of patient privacy, regardless of the fact that specific names are not used.
Many believe records can be easily matched with employees and would encourage discrimination or job loss for high-cost beneficiaries.
Insurers that fail to comply face fines of up to $25,000.
2023 Drug Trend Report - Xevant
May 16th 2024To effectively navigate the changing pharmacy landscape and maintain a robust, cost-effective pharmacy benefit, you must understand the forces behind rising drug trend. What’s driving your costs and what can you do about it? As a leader in the PBM analytics space, we offer a unique perspective on pivotal trend drivers. Here’s what our comprehensive analysis revealed: -A surge in utilization rates across specialty and non-specialty drugs, magnified by anti-obesity therapies -Financial strain imposed by anti-inflammatory biologics and the yet-to-be-fulfilled -promise of biosimilar savings -Persistent price inflation driving higher costs year over year
Read More